Skip to content
Therapy areas
Menu Toggle
About colorectal cancer
Folates in cancer treatment
Other forms of cancer
Our drug candidate
Menu Toggle
About arfolitixorin
Menu Toggle
The evidence platform
All clinical studies
Publications
The phase Ib/II study
Intellectual property rights
Investors
Menu Toggle
Financial reports
Financial calendar
The share and shareholders
Corporate governance
Menu Toggle
Corporate governance reports
Articles of association
General meetings
Menu Toggle
Annual General Meeting, May 19, 2026
Previous general meetings
Board
Work of the board
Remuneration committee
Menu Toggle
Remuneration
Incentive programs
Audit committee
Auditor
Nomination committee
Prospects and rights issue
Menu Toggle
Warrants of 2026, series TO1
Right issue 2025
Previous listing prospect and rights issue
Company presentations
Analysts
Investor relations contact
Media
Menu Toggle
Press releases
Image bank
Subscribe
About Isofol
Menu Toggle
Vision and goal
Our strategy
Market potential
Management and team
Board
Scientific Advisors
Partners
The missing link
Our history
Contact
Search for:
Search
Search
EN
English
Svenska
Main Menu
Therapy areas
Menu Toggle
About colorectal cancer
Folates in cancer treatment
Other forms of cancer
Our drug candidate
Menu Toggle
About arfolitixorin
Menu Toggle
The evidence platform
All clinical studies
Publications
The phase Ib/II study
Intellectual property rights
Investors
Menu Toggle
Financial reports
Financial calendar
The share and shareholders
Corporate governance
Menu Toggle
Corporate governance reports
Articles of association
General meetings
Menu Toggle
Annual General Meeting, May 19, 2026
Previous general meetings
Board
Work of the board
Remuneration committee
Menu Toggle
Remuneration
Incentive programs
Audit committee
Auditor
Nomination committee
Prospects and rights issue
Menu Toggle
Warrants of 2026, series TO1
Right issue 2025
Previous listing prospect and rights issue
Company presentations
Analysts
Investor relations contact
Media
Menu Toggle
Press releases
Image bank
Subscribe
About Isofol
Menu Toggle
Vision and goal
Our strategy
Market potential
Management and team
Board
Scientific Advisors
Partners
The missing link
Our history
Contact
Search for:
Search
Search
EN
English
Svenska
Main Menu
ABG Sundal Collier Investor Days, Stockholm
By
Jenny Brinkeby
/
December 4, 2025
Previous
Redeye Fight Cancer Day, Stockholm
Next
Stora Aktiedagarna
×
Meny
EN
English
Svenska
Sök efter:
Therapy areas
About colorectal cancer
Folates in cancer treatment
Other forms of cancer
Our drug candidate
About arfolitixorin
The evidence platform
All clinical studies
Publications
The phase Ib/II study
Intellectual property rights
Investors
Financial reports
Financial calendar
The share and shareholders
Corporate governance
Corporate governance reports
Articles of association
General meetings
Annual General Meeting, May 19, 2026
Previous general meetings
Board
Work of the board
Remuneration committee
Remuneration
Incentive programs
Audit committee
Auditor
Nomination committee
Prospects and rights issue
Warrants of 2026, series TO1
Right issue 2025
Previous listing prospect and rights issue
Company presentations
Analysts
Investor relations contact
Media
Press releases
Image bank
Subscribe
About Isofol
Vision and goal
Our strategy
Market potential
Management and team
Board
Scientific Advisors
Partners
The missing link
Our history
Contact
Scroll to Top
